Analysts are weighing in on obesity-device maker EnteroMedics Inc (NASDAQ:ETRM), stem cell company Athersys, Inc. (NASDAQ:ATHX) and cancer vaccine maker Inovio Pharmaceuticals Inc (NASDAQ:INO), with price targets ranging from …
Athersys, Inc. (NASDAQ:ATHX) announced positive results from the analysis of one-year follow-up data from its Phase 2 clinical study of the intravenous administration of …
Athersys, Inc. (NASDAQ:ATHX) announced the recent publication of an article in the peer-reviewed Journal of Neuroinflammation that provides further evidence that multipotent adult progenitor …
While shares of stem cell company Athersys, Inc. (NASDAQ:ATHX) are trading up over 20% following new partnership agreement in Japan, shares of biotech company Caladrius Biosciences …
Athersys, Inc. (NASDAQ:ATHX) and Healios K.
Athersys, Inc. (NASDAQ:ATHX) announced hat multipotent adult progenitor cells (MAPC®), used in Athersys’ MultiStem® cell therapy currently in clinical development, are effective in improving …
Athersys, Inc. (NASDAQ:ATHX) announced its financial results for the three months ended September 30, 2015.
Athersys, Inc. (NASDAQ:ATHX) announced that Athersys and Chugai Pharmaceutical Co.
Recently, various executives have taken part in insider selling activity for the stocks of Athersys, Inc.(NASDAQ:ATHX), Neuralstem, Inc.
Athersys, Inc. (NASDAQ:ATHX) announced its financial and operating results for the three months ended June 30, 2015.
